The blood gas analyzers market is expected to reach USD 636.0 million by 2021 from USD 506.9 million in 2016, at a CAGR of 4.6%. Major factors driving the growth of this market include the rising geriatric population and the subsequent growth in prevalence of chronic diseases, and growing demand for point-of-care analyzers.
Furthermore, the growth in demand for integrated combined systems and miniaturization of POC blood gas analyzers are expected to support market growth. The global blood gas analyzers market is segmented based on players, major brands, and regions. GEM 3000 (Instrumentation Laboratory) is expected to account for the largest share of the global blood gas analyzers market in 2016, while ePOC (Alere) will be the fastest-growing product segment in the coming years.
Geographically, the blood gas analyzers market is dominated by North America, followed by Europe, APAC, and the Rest of the World (RoW). Growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives are some of the key factors responsible for the large share of North America in the global market.
Asia-Pacific is estimated to be the fastest-growing regional segment during the forecast period. Japan, China, and India are the major contributors to the Asia-Pacific blood gas analyzers market. Factors such as growing initiatives by market players, increasing patient population base, and rising number of partnerships and joint ventures are driving the Asia-Pacific market.
This report provides market sizing of companies and their brands in terms of value and volume (per-year sales). In addition to market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years.
Also, company profiles comprise the product portfolios, developments, and strategies adopted by market players to maintain and increase their shares in the market. The abovementioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.
The major players in the global blood gas analyzers market are Abbott Laboratories (U.S.), Alere, Inc. (U.S.), Instrumentation Laboratory (U.S.), Radiometer (Denmark), Roche Diagnostics (Switzerland), and Siemens Healthcare (Germany).
Key Topics Covered:
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Global Blood Gas Analyzer Market Revenue, By Company
6. Global Blood Gas Analyzer Market Revenue, By Product
7. Blood Gas Analyzer Market, By Region
8. Competitive Landscape
9. Company Profiles
- Abbott Laboratories, Inc.
- ERBA Diagnostics Mannheim GmbH
- Instrumentation Laboratory (A Werfen Company)
- Medica Corporation
- Nova Biomedical
- OPTI Medical Systems, Inc. (A Subsidiary of Idexx Laboratories, Inc.)
- Radiometer Medical Aps (A Subsidiary of Danaher Corporation)
- Roche Diagnostics Limited
- Siemens AG
For more information visit http://www.researchandmarkets.com/research/xzv8s5/blood_gas
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/blood-gas-analyzerblood-gas-and-electrolyte-analyzer-market-by-productbrand-playercompany---global-forecasts-to-2021---research-and-markets-300302672.html
SOURCE Research and Markets